Stantec, a specialist cancer centre design company, has been selected to design the Ben Stelter Proton Facility and Neuroscience Centre of Excellence in Edmonton, Canada.
This will be Canada’s first cancer care facility offering proton therapy.
Located near the University of Alberta Cross Cancer Institute and Stollery Children’s Hospital, the centre will be owned and operated by WestCan Proton Therapy.
Highcroft Healthcare Solutions will manage the financing and development of the project.
The University of Pennsylvania Department of Radiation Oncology will provide clinical education, training, and standards to support the delivery of safe and quality care.
This will be Canada’s first cancer care facility offering proton therapy
Gordon Baltzer, CEO of WestCan Proton Therapy, said: "We couldn’t be more proud of our industry partners who are bringing their expertise to this project. Stantec offers a wealth of experience in delivering projects that set a new standard in excellence."
"At WestCan, we are dedicated to providing the very best in cancer treatment. This facility will ensure that proton therapy is accessible for all Canadians and will serve as a model for future projects around the world," Baltzer concluded.
Malcolm Bruce, CEO for Edmonton Global, said: "This project is a first not only for the Edmonton region, but a first for Canada and Stantec is the right partner to take on the incredible design we expect for this centre of excellence."
"We take immense pride in being the chosen location for this remarkable facility, and we’re equally proud that a home-grown and global success story has been selected to lead its design,” Bruce concluded.
